The Latest Breaking News from Oxford Vaccine Group

First human volunteer vaccinated against Bundibugyo strain of Ebola

The University of Oxford 's Oxford Vaccine Group has vaccinated the first volunteer in the world's inaugural clinical trial for a vaccine against the Bundibugyo strain of Ebola . This marks the first human administration of the ChAdOx1 BDBV vaccine, which was developed by Oxford scientists using the same technology…

The Independent UK · Jul 30

It’s not just Covid: the triple threat that could overwhelm the NHS this winter

A severe flu outbreak or new coronavirus variant could prove catastrophic, says Andrew Pollard, director of the Oxford Vaccine Group

The Guardian - UK · Sep 7, 2022

Vaccine chief claims Covid booster jabs will stop NHS being overrun this winter

The top-up doses of the vaccine are aiming to cut the number of patients admitted to hospital in the winter, according to Oxford Vaccine Group director Professor Sir Andrew Pollard.

Glasgow Live · Aug 30, 2022

Monkeypox needs 'substantial public health response' warns Covid expert

While the virus does not spread as easily as Covid-19 it still needs to be tackled correctly

Wales Online · Jun 8, 2022

Monkeypox needs ‘substantial public health response’, says Covid vaccine expert

Professor Sir Andrew Pollard was speaking after being knighted by the Prince of Wales at Windsor Castle.

The Independent UK · Jun 8, 2022

Monkeypox: World ‘cannot take eye off the ball’ over infectious diseases, Oxford vaccine chief warns

Professor Sir Andrew Pollard, director of the Oxford Vaccine Group, calls for immediate investment into pandemic preparedness

The Independent UK · May 23, 2022

Oxford Covid jab gears up for final act: saving the rest of the world

After mishaps and misinformation, jab will build ‘global wall of immunity’, says director of Oxford Vaccine Group

The Guardian - UK · Mar 20, 2022